Skip to main content
OpenTrials

Clinical trial condition

Scleroderma, Systemic

Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.

109 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma, Systemic trial results

Completed

Fresolimumab In Systemic Sclerosis

NCT01284322

Conditions
Connective Tissue Diseases, Diffuse Systemic Sclerosis, Scleroderma, Diffuse, +3 more
Locations
  • Boston University School of Medicine; Rheumatology/Arthritis Center Boston, Massachusetts, United States
View Trial Details
Completed

A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With Scleroderma

NCT00930683

Conditions
Connective Tissue Diseases, Scleroderma, Scleroderma, Diffuse, +3 more
Locations
  • Research Site Los Angeles, California, United States
  • Boston University Boston, Massachusetts, United States
  • Research Site Ann Arbor, Michigan, United States
  • Research Site New Brunswick, New Jersey, United States
View Trial Details
Completed

Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis

NCT00764309

Conditions
Connective Tissue Diseases, Scleroderma, Scleroderma, Diffuse, +3 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Ucla Division Of Rheumatology Los Angeles, California, United States
  • University Of Connecticut Health Center Farmington, Connecticut, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 13 locations
View Trial Details

Related conditions